Arnab Sarkar

688 total citations
37 papers, 400 citations indexed

About

Arnab Sarkar is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Arnab Sarkar has authored 37 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in Arnab Sarkar's work include MicroRNA in disease regulation (4 papers), Computational Drug Discovery Methods (4 papers) and Natural Antidiabetic Agents Studies (3 papers). Arnab Sarkar is often cited by papers focused on MicroRNA in disease regulation (4 papers), Computational Drug Discovery Methods (4 papers) and Natural Antidiabetic Agents Studies (3 papers). Arnab Sarkar collaborates with scholars based in India, Saudi Arabia and Norway. Arnab Sarkar's co-authors include Tapan Kumar Maity, Shanta Dutta, Alok K. Chakrabarti, Pabitra Chattopadhyay, Koushik Dhara, Sanmoy Karmakar, Asim K. Duttaroy, Sanjay Basak, Sujay Mukhopadhyay and Rakesh Kundu and has published in prestigious journals such as PLoS ONE, Journal of Hazardous Materials and Biochemical Pharmacology.

In The Last Decade

Arnab Sarkar

36 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnab Sarkar India 12 159 46 43 42 34 37 400
Xiaoxia Zheng China 14 241 1.5× 20 0.4× 61 1.4× 89 2.1× 17 0.5× 29 559
David Mitchell United States 14 341 2.1× 19 0.4× 21 0.5× 36 0.9× 15 0.4× 18 672
Valnês S. Rodrigues-Junior Brazil 14 241 1.5× 20 0.4× 36 0.8× 96 2.3× 16 0.5× 55 544
Anna A. Emelianova Russia 6 256 1.6× 13 0.3× 60 1.4× 31 0.7× 9 0.3× 7 590
Virginia Flores‐Morales Mexico 11 142 0.9× 18 0.4× 60 1.4× 101 2.4× 9 0.3× 28 487
Stephanie A. Sweetana United States 10 115 0.7× 56 1.2× 25 0.6× 48 1.1× 17 0.5× 12 531
Katarzyna Macur Poland 11 110 0.7× 18 0.4× 24 0.6× 55 1.3× 7 0.2× 27 330
Ljubica Šuturkova North Macedonia 14 179 1.1× 76 1.7× 111 2.6× 38 0.9× 12 0.4× 52 606
Vinitha Ramanath Pai India 11 139 0.9× 25 0.5× 27 0.6× 113 2.7× 12 0.4× 28 397

Countries citing papers authored by Arnab Sarkar

Since Specialization
Citations

This map shows the geographic impact of Arnab Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnab Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnab Sarkar more than expected).

Fields of papers citing papers by Arnab Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnab Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnab Sarkar. The network helps show where Arnab Sarkar may publish in the future.

Co-authorship network of co-authors of Arnab Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Arnab Sarkar. A scholar is included among the top collaborators of Arnab Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnab Sarkar. Arnab Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Arnab, et al.. (2025). Molecular insights into cobalt homeostasis in estuarine microphytobenthos: A meta-transcriptomics and biogeochemical approach. Journal of Hazardous Materials. 490. 137716–137716.
2.
3.
Sarkar, Arnab, et al.. (2025). MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy. Frontiers in Pharmacology. 16. 1613844–1613844. 1 indexed citations
4.
Sarkar, Arnab, et al.. (2024). Insights into Antihypertensive Medication Adherence: A Tertiary Care Teaching Hospital Study on Patient Compliance and Influencing Factors. International Journal of Pharmaceutical Investigation. 14(2). 525–530. 1 indexed citations
5.
6.
7.
8.
Sarkar, Arnab, et al.. (2024). Unanticipated Second Leg Bilateral Below Knee Amputation in a Diabetic Amputee: A Case Report. Journal of Young Pharmacists. 16(3). 601–603. 1 indexed citations
9.
10.
Sarkar, Arnab, et al.. (2024). Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics. Biochemical Pharmacology. 221. 116041–116041. 9 indexed citations
11.
Sarkar, Arnab, et al.. (2024). Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement. Inflammation Research. 73(5). 877–896. 2 indexed citations
12.
Sarkar, Arnab, et al.. (2023). Structural and molecular insights of protein tyrosine phosphatase 1B (PTP1B) and its inhibitors as anti-diabetic agents. Journal of Molecular Structure. 1293. 136258–136258. 19 indexed citations
13.
Sarkar, Arnab, et al.. (2023). Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer. European Journal of Pharmacology. 944. 175588–175588. 28 indexed citations
14.
Sarkar, Arnab, Sourav Ghoshal, Sujay Mukhopadhyay, et al.. (2023). Endoplasmic reticulum-targeted fluorescent probes for metal-free tracking of carbon monoxide in living cells. Sensors and Actuators B Chemical. 393. 134150–134150. 7 indexed citations
15.
16.
Das, Bhaskar, Pardeep Kumar Bhardwaj, Nanaocha Sharma, et al.. (2023). Evaluation of Mollugo oppositifolia Linn. as cholinesterase and β-secretase enzymes inhibitor. Frontiers in Pharmacology. 13. 990926–990926. 5 indexed citations
17.
Sarkar, Arnab, et al.. (2023). Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships. European Journal of Medicinal Chemistry. 264. 115990–115990. 4 indexed citations
18.
Sarkar, Arnab, et al.. (2022). Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis. PLoS ONE. 17(9). e0273006–e0273006. 3 indexed citations
19.
Sarkar, Arnab, et al.. (2021). Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors. Bioorganic & Medicinal Chemistry. 46. 116301–116301. 15 indexed citations
20.
Sarkar, Arnab, et al.. (2021). Understanding stem cells and its pivotal role in regenerative medicine. Life Sciences. 273. 119270–119270. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoxia Zheng Breakdown of academic impact, for papers by David Mitchell Breakdown of academic impact, for papers by Valnês S. Rodrigues-Junior Breakdown of academic impact, for papers by Anna A. Emelianova Breakdown of academic impact, for papers by Virginia Flores‐Morales Breakdown of academic impact, for papers by Stephanie A. Sweetana Breakdown of academic impact, for papers by Katarzyna Macur Breakdown of academic impact, for papers by Ljubica Šuturkova Breakdown of academic impact, for papers by Vinitha Ramanath Pai
Rankless by CCL
2026